Literature DB >> 28972582

Do significant TFE3 gene rearrangements occur in succinate dehydrogenase-deficient renal cell carcinoma? Borderline FISH results should be interpreted with caution.

Angela Chou1,2,3, Ondrej Hes4, John Turchini3,4,5, Kiril Trpkov6, Anthony J Gill3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28972582     DOI： 10.1038/modpathol.2017.77

Source DB:  PubMed          Journal:  Mod Pathol        ISSN： 0893-3952            Impact factor:   7.842


× No keyword cloud information.
  6 in total

1.  Renal cell carcinoma with TFE3 translocation and succinate dehydrogenase B mutation.

Authors:  Anna Calió; David J Grignon; Bradley A Stohr; Sean R Williamson; John N Eble; Liang Cheng
Journal:  Mod Pathol       Date:  2016-12-02       Impact factor: 7.842

2.  Section E9 of the American College of Medical Genetics technical standards and guidelines: fluorescence in situ hybridization.

Authors:  James T Mascarello; Betsy Hirsch; Hutton M Kearney; Rhett P Ketterling; Susan B Olson; Denise I Quigley; Kathleen W Rao; James H Tepperberg; Karen D Tsuchiya; Anne E Wiktor
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

3.  Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

Authors:  Whitney M Green; Raluca Yonescu; Laura Morsberger; Kerry Morris; George J Netto; Jonathan I Epstein; Peter B Illei; Mohamad Allaf; Marc Ladanyi; Constance A Griffin; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-08       Impact factor: 6.394

4.  TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.

Authors:  Qiu Rao; Sean R Williamson; Shaobo Zhang; John N Eble; David J Grignon; Mingsheng Wang; Xiao-Jun Zhou; Wenbin Huang; Puay-Hoon Tan; Gregory T Maclennan; Liang Cheng
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

Review 5.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

Authors:  Holger Moch; Antonio L Cubilla; Peter A Humphrey; Victor E Reuter; Thomas M Ulbright
Journal:  Eur Urol       Date:  2016-02-28       Impact factor: 20.096

6.  Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.

Authors:  Anthony J Gill; Ondrej Hes; Thomas Papathomas; Monika Šedivcová; Puay Hoon Tan; Abbas Agaimy; Per Arne Andresen; Andrew Kedziora; Adele Clarkson; Christopher W Toon; Loretta Sioson; Nicole Watson; Angela Chou; Julie Paik; Roderick J Clifton-Bligh; Bruce G Robinson; Diana E Benn; Kirsten Hills; Fiona Maclean; Nicolasine D Niemeijer; Ljiljana Vlatkovic; Arndt Hartmann; Eleonora P M Corssmit; Geert J L H van Leenders; Christopher Przybycin; Jesse K McKenney; Cristina Magi-Galluzzi; Asli Yilmaz; Darryl Yu; Katherine D Nicoll; Jim L Yong; Mathilde Sibony; Evgeny Yakirevich; Stewart Fleming; Chung W Chow; Markku Miettinen; Michal Michal; Kiril Trpkov
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394
  6 in total
  1 in total

1.  Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis.

Authors:  Yiqi Zhu; Xiaohong Pu; Xiang Dong; Changwei Ji; Hongqian Guo; Dongmei Li; Xiaozhi Zhao; Weidong Gan
Journal:  Cancer Manag Res       Date:  2021-03-15       Impact factor: 3.989
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.